scPharmaceuticals Inc. financial data

Symbol
SCPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
25 Burlington Mall Road, Suite 203, Burlington, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 663 % -53.6%
Quick Ratio 96.6 % +77.6%
Debt-to-equity 257 % +218%
Return On Equity -315 % -309%
Return On Assets -88.2 % -107%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50M shares +39.5%
Common Stock, Shares, Outstanding 50M shares +39.5%
Entity Public Float 274M USD +263%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 46.6M shares +20.1%
Weighted Average Number of Shares Outstanding, Diluted 46.6M shares +20.1%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 9.17M USD +207%
Research and Development Expense 12.3M USD +13.8%
General and Administrative Expense 20.6M USD +111%
Operating Income (Loss) -63.7M USD -28.3%
Net Income (Loss) Attributable to Parent -80.1M USD -59.4%
Earnings Per Share, Basic -1.9 USD/shares -38.7%
Earnings Per Share, Diluted -1.9 USD/shares -38.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91.5M USD +161%
Accounts Receivable, after Allowance for Credit Loss, Current 9.22M USD +121%
Inventory, Net 18.1M USD +154%
Other Assets, Current 340K USD +2991%
Assets, Current 123M USD +18.2%
Property, Plant and Equipment, Net 51K USD +30.8%
Operating Lease, Right-of-Use Asset 1.33M USD -13.4%
Assets 125M USD +17.9%
Accounts Payable, Current 5M USD +48.5%
Employee-related Liabilities, Current 3.89M USD +29%
Accrued Liabilities, Current 9.87M USD +38.8%
Liabilities, Current 15.3M USD +39.4%
Operating Lease, Liability, Noncurrent 1.17M USD -10.4%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 94.4M USD +65.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD -103%
Retained Earnings (Accumulated Deficit) -348M USD -29.9%
Stockholders' Equity Attributable to Parent 30.7M USD -37.5%
Liabilities and Equity 125M USD +17.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.7M USD -7.32%
Net Cash Provided by (Used in) Financing Activities 13.7M USD
Net Cash Provided by (Used in) Investing Activities 29.3M USD +319%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 50M shares +39.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11.6M USD +176%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 91.5M USD +161%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.47M USD -1.08%
Deferred Tax Assets, Valuation Allowance 73.2M USD +23.8%
Deferred Tax Assets, Gross 74.3M USD +24.9%
Operating Lease, Liability 1.4M USD -9.87%
Depreciation 22K USD -18.5%
Payments to Acquire Property, Plant, and Equipment 6K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -80.1M USD -59.4%
Lessee, Operating Lease, Liability, to be Paid 1.83M USD -14.6%
Property, Plant and Equipment, Gross 128K USD -47.8%
Operating Lease, Liability, Current 231K USD -6.86%
Lessee, Operating Lease, Liability, to be Paid, Year Two 376K USD +10.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 381K USD +12.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 429K USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three 358K USD +2.58%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.24M USD +11.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 367K USD +2.51%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 5.57M USD +33.4%
Interest Expense 8.18M USD +2.33%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%